Enriched Withania somnifera Based Dietary Composition and a Method Thereof
AssigneeArjuna Natural Private Limited
InventorBenny ANTONY
Life of this patent
Estimating the term…
Abstract
A unit dosage of an oral composition of an extract of Withania somnifera is disclosed. The extract of Withania somnifera includes total withanolides. The total withanolides includes withanolide glycosides and withanolide aglycones. The extract of Withania somnifera includes about 32% to about 38% by weight of the withanolide glycosides. Methods of preparing the extract of Withania somnifera are disclosed. Methods of treatment by administering the extract of Withania somnifera are disclosed.
Claims5
A method of enhancing bioavailability of the total withanolides in a subject, the method comprising administering a unit dosage of an oral composition of an extract of Withania somnifera to a subject in need thereof,
- wherein the extract of Withania somnifera comprises total withanolides,
- wherein the total withanolides comprise withanoilide glycosides and withanolide aglycones, wherein the extract of Withania somnifera comprises about 32% to about 38% by weight of the withanolide glycosides,
- wherein the withanolide glycosides comprise withanoside IV, and the withanolide aglycones comprise withanolide A and withaferin A, and
- wherein the extract of Withania somnifera comprises a ratio of withanoside IV:withaferin A in a range of about 1:3 w/w to about 3:1 w/w.
A method to increase the oral bioavailability of the withaferin A, the method comprising administering a unit dosage of an oral composition of an extract of Withania somnifera of to a subject in need thereof,
- wherein the extract of Withania somnifera comprises total withanolides,
- wherein the total withanolides comprise withanoilide glycosides and withanolide aglycones,
- wherein the extract of Withania somnifera comprises about 32% to about 38% by weight of the withanolide glycosides,
- wherein the withanolide glycosides comprise withanoside IV, and the withanolide aglycones comprise withanolide A and withaferin A, and
- wherein the extract of Withania somnifera comprises a ratio of withanoside IV:withaferin A in a range of about 1:3 w/w to about 3:1 w/w.
A method to increase the oral bioavailability of the withanoside IV, the method comprising administering a unit dosage of an oral composition of an extract of Withania somnifera to a subject in need thereof,
- wherein the extract of Withania somnifera comprises total withanolides,
- wherein the total withanolides comprise withanoilide glycosides and withanolide aglycones,
- wherein the extract of Withania somnifera comprises about 32% to about 38% by weight of the withanolide glycosides,
- wherein the withanolide glycosides comprise withanoside IV, and the withanolide aglycones comprise withanolide A and withaferin A, and
- wherein the extract of Withania somnifera comprises a ratio of withanoside IV:withaferin A in a range of about 1:3 w/w to about 3:1 w/w.
Dependencies are inferred from the claim text.